Search results for "Diabetic macular edema"


 
Results 1 - 10 of about 12 for "Diabetic macular edema".
Sort by: Relevance | Newest | Oldest

Cystatin C levels associated with risk of sight-threatening diabetic retinopathy

The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
https://diabetes.acponline.org/archives/2022/05/13/3.htm
13 May 2022

Surgical, drug treatments have similar outcomes in patients with vitreous hemorrhage from proliferative diabetic retinopathy

A randomized trial found equivalent improvements in visual acuity at two years with either therapy but identified some differences in outcomes that could help patients and clinicians choose a treatment method.
https://diabetes.acponline.org/archives/2021/01/08/2.htm
8 Jan 2021

Spotlight on artificial intelligence and diabetic retinopathy

One recent study reported on the development and validation of an artificial intelligence algorithm for detecting diabetic retinopathy, while another tested such technology in primary care.
https://diabetes.acponline.org/archives/2018/10/12/6.htm
12 Oct 2018

Macular edema, cardiovascular disease associated in type 2 diabetes

Patients with diabetic macular edema or proliferative diabetic retinopathy should be followed more actively to prevent cardiovascular disease, study authors said.
https://diabetes.acponline.org/archives/2017/05/12/1.htm
12 May 2017

Results appear similar at 2 years for diabetic macular edema drugs

Eyes were assigned to receive 2.0 mg aflibercept, 1.25 mg repackaged (compounded) bevacizumab, or 0.3 mg ranibizumab. Intravitreous injections were administered up to once per month according to a follow-up and retreatment regimen specified by protocol.
https://diabetes.acponline.org/archives/2016/03/11/3.htm
11 Mar 2016

Aflibercept approved for diabetic retinopathy in diabetic macular edema

Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.
https://diabetes.acponline.org/archives/2015/04/10/7.htm
10 Apr 2015

Spotlight on diabetic macular edema

Two recent studies analyzed treatment of diabetic macular edema with drugs that block vascular endothelial growth factor.
https://diabetes.acponline.org/archives/2015/03/13/10.htm
13 Mar 2015

Glucose monitoring app, weight-loss device, medications approved

The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.
https://diabetes.acponline.org/archives/2015/02/13/7.htm
13 Feb 2015

Spotlight on diabetic eye disease

The prevalence and treatment of diabetes complications affecting the eye were analyzed by multiple studies published in the past month.
https://diabetes.acponline.org/archives/2014/01/10/8.htm
10 Jan 2014

Spotlight on European Association for the Study of Diabetes conference

The annual meeting of the European Association for the Study of Diabetes was held in Barcelona, Spain in September. Research presented at the meeting covered risks of sulfonylureas, pioglitazone and macular edema, treatment intensification and erectile dysfunction.
https://diabetes.acponline.org/archives/2013/10/11/10.htm
11 Oct 2013

Result Page: Prev   1   2   Next